Esperion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're continuing the 2021 Healthcare Conference this morning with Esperion.
I'm joined by the company's CEO, Tim Mayleben. But a quick housekeeping note, instead of moving across the hall to the breakout room this year, you've got a blue ask-a-question button as you watch the webcast, you can use that to send a question through the portal, it'll pop up on my end, and I can use those during the Q&A session that will follow the presentation.
You can do that anytime either during Q&A or during the presentation, and it'll just kind of queue up for me. But without any further ado, let me turn it over to Tim.
Thank you, Jess, and good morning, everyone. I'm on Slide 1. I want to thank Jess and her team for the opportunity to tell you about Esperion this morning. My name is, as Jess said,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
